Evidence map›Paper›PMID 24438460›Full record

Trial reportBMC public health2014

Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10-14 UK (SFP 10-14 UK).

Jeremy Segrott, David Gillespie, Jo Holliday, Ioan Humphreys, Simon Murphy, Ceri Phillips, Hayley Reed, Heather Rothwell, David Foxcroft, Kerenza Hood and 4 more

Abstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in BMC public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Family-based prevention programmes for alcohol use in young people.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jeremy SegrottCentre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), Cardiff School of Social Sciences, Cardiff University, 1-3 Museum Place, CF10 3BD Cardiff, UK. segrottj@cardiff.ac.uk.
David Gillespie
Jo Holliday
Ioan Humphreys
Simon Murphy
Ceri Phillips
Hayley Reed
Heather Rothwell
David Foxcroft
Kerenza Hood
Zoe Roberts
Jonathan Scourfield
Claire Thomas
Laurence Moore

Funding

Biotechnology and Biological Sciences Research CouncilBritish Heart FoundationCancer Research UKChief Scientist Office SPHSU1Medical Research Council G0802128Medical Research Council MC_UU_12017/4Medical Research Council MR/K023233/1Wellcome Trust 087640MA
6 · The paper itself

Abstract

backgroundPrevention of alcohol, drug and tobacco misuse by young people is a key public health priority. There is a need to develop the evidence base through rigorous evaluations of innovative approaches to substance misuse prevention. The Strengthening Families Programme 10-14 is a universal family-based alcohol, drugs and tobacco prevention programme, which has achieved promising results in US trials, and which now requires cross-cultural assessment. This paper therefore describes the protocol for a randomised controlled trial of the UK version of the Strengthening Families Programme 10-14 (SFP 10-14 UK). METHODS/

designThe trial comprises a pragmatic cluster randomised controlled effectiveness trial with families as the unit of randomisation, with embedded process and economic evaluations. Participating families will be randomised to one of two treatment groups - usual care with full access to existing services (control group), or usual care plus SFP 10-14 UK (intervention group). The trial has two primary outcomes - the number of occasions that young people report having drunk alcohol in the last 30 days, and drunkenness during the last 30 days, both dichotomised as 'never' and '1-2 times or more'. The main follow-up is at 2 years past baseline, and short-term and intermediate outcomes are also measured at 9 and 15 months. DISCUSSION: The results from this trial will provide evidence on the effectiveness and cost-effectiveness of an innovative universal family-based substance misuse prevention programme in a UK context.

trial registrationCurrent Controlled Trials ISRCTN63550893.

Indexed as

Program EvaluationAdolescentAlcohol DrinkingAlcoholic IntoxicationAlcoholismChildCost-Benefit AnalysisFamilyFemaleHumansMaleResearch DesignUnited Kingdom

Identifiers

PMID24438460
PMCPMC3902023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.